A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Vericel Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 46,200 shares of VCEL stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,200
Previous 71,800 35.65%
Holding current value
$2.01 Million
Previous $3.94 Million 47.72%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$44.5 - $61.8 $1.14 Million - $1.58 Million
-25,600 Reduced 35.65%
46,200 $2.06 Million
Q4 2024

Feb 14, 2025

BUY
$40.05 - $59.11 $2.88 Million - $4.24 Million
71,800 New
71,800 $3.94 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.05B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.